Hepatitis induced by danazol in a patient w/ functional deficit of CI-inhibitor [1];Hepatitis por danazol paciente con déficit funcional de CI inhibidor

Anales de Medicina Interna

Volumn 18, Issue 11, 2001, Pages 605-606

  Estrada Rodriguez J L ^a   Jorquera Plaza, F ^a   Gozalo Reques, F ^a   Alvarez Puebla M J ^a  

^a Hospital e León   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; DANAZOL; ANTIESTROGEN; COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DYSPHONIA; DYSPNEA; FACE EDEMA; HEPATITIS; HERNIA; HUMAN; LETTER; MALE; TREATMENT OUTCOME; TOXIC HEPATITIS;

ADULT; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; DANAZOL; ESTROGEN ANTAGONISTS; HEPATITIS, TOXIC; HUMANS; MALE;

EID: 2242448820     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. An apparent danazol-induced primary hepatocellular carcinoma: Case report
2. Danazol therapy: An unusual aetiology of hepatocellular carcinoma
3. Hepatosplenic peliosis after danazol and glycocorticoids for ITP
4. Fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol
5. Danazol y hepatitis colestática
6. Acquired angioedema
7. Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients
8. Tratamiento de la púrpura trombopénica idiopática con danazol
9. Long-Term Danazol therapy in autoimmune thrombocytopenia: Unmaintained remission and age-dependent response in women